Hover a dot or row, or tab through the dots · bars scaled to the largest round ($248M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-115176
First filed2009-07-23
Latest2011-03-29
Sought$372M
Sold$248M
Investors4
Exemptions506
Who backs Inspiration Biopharmaceuticals Inc, inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2011-03-29
Related persons
Name
Relationship
Clarification
John R. Taylor
RelationshipDirector, Promoter
ClarificationCo-Founder of Inspiration Biopharmaceuticals, Inc., and Chairman of the Board of Directors.
Scott D. Martin
RelationshipDirector, Promoter
ClarificationCo-Founder of Inspiration Biopharmaceuticals, Inc., and Member of the Board of Directors.
Michael J. Giffith
RelationshipExecutive Officer, Director
ClarificationPresident and Chief Executive Officer of Inspiration Bipharmaceuticals, Inc., and Member of the Board of Directors.
Gordon H. Busenbark
RelationshipExecutive Officer
ClarificationChief Finanacial Officer, Secretary, and Treasurer.
Barry R. Frankel
RelationshipDirector
ClarificationMember of the Board of Directors.
Stephen R. Evans-Freke
RelationshipDirector
ClarificationMember of the Board of Directors.
Andrew Grethlein
RelationshipExecutive Officer
ClarificationChief Operating Officer.
Gerard Picot
RelationshipDirector
ClarificationMember of the Board of Directors.
Karen Dawes
RelationshipDirector
ClarificationMember of the Board of Directors.
Sales compensation
Named in Item 12 of its Form D filings
Sales compensation recipients
Recipient
CRD
Broker-dealer
Offerings
Healthios, Inc.
CRD—
Broker-dealer—
Offerings1
Facts
As its latest Form D states them
Industry
Biotechnology
State
California (CA)
Exemptions
Rule 506
First filed
2009-07-23
Latest filing
2011-03-29
Minimum investment
$435K
Who backs Inspiration Biopharmaceuticals Inc
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)